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The cell-death machine
Arul M. Chinnaiyan and Vishva M. Dixit
Apoptosis, or programmed cell death, is the physiological
process whereby individual cells are deliberately eliminated to
achieve homeostasis and proper metazoan development.
Numerous genes have recently been identified that are
involved in apoptosis: some are believed to encode death
effectors, whereas others encode positive or negative
regulators of the cell-death machine. Precisely how these
various proteins interact in the molecular mechanism of
apoptosis remains to be discovered.
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Introduction
In the multicellular organism, genetically regulated mech-
anisms determine not only which cells live, but also which
cells die [1]. In the adult, steady-state condition, cell divi-
sion must be counterbalanced by cell death. This physio-
logically important cell death is an active process, known
as programmed cell death, or apoptosis. Apoptosis is char-
acterized by profound morphological alterations of the cell
and, specifically, the nucleus. Typically, apoptotic
changes include cellular shrinkage, membrane blebbing
and chromatin condensation [2]. The nuclear DNA of
apoptotic cells is often fragmented into oligonucleosomal-
sized units [3]. By contrast, ‘accidental’ cell death, or
necrosis, is caused by an overwhelming injury resulting in
cellular swelling and loss of membrane integrity [4].
Cell proliferation has been studied extensively, but genes
regulating cell death have only recently attracted the
attention of the biomedical research community. Perturba-
tions of apoptosis contribute to the pathogenesis of several
human diseases including cancer, acquired immuno-
deficiency syndrome and neurodegenerative disorders [5].
Thus, discovering ways to modulate apoptosis may have
immense therapeutic potential. The fundamental impor-
tance of the cell-death pathway is further emphasized by
its conservation throughout evolution [6]. In fact, genetic
studies of two invertebrates, Caenorhabditis elegans and
Drosophila melanogaster, have provided the most insight
into the genes controlling apoptosis [7]. In this review, we
focus on the effectors, inhibitors and activators of the cell-
death pathway, and how they may function as a fine-tuned
cell-suicide machine. We shall not discuss certain impor-
tant regulators of apoptosis, such as p53, Rb and c-Myc,
which have been covered in other recent reviews [8,9].
The engine of cell death
It is becoming apparent that proteases play an important
part in the apoptotic mechanism [10]. Protease inhibitors
of various specificities have been shown to inhibit cell
death [11]. Furthermore, granzyme B, an aspartate-specific
serine protease, is an important component of cytotoxic T-
cell-mediated apoptosis [12,13]. Purified granzyme B, in
combination with perforin, a pore-forming protein, induces
rapid apoptosis of various target cell lines [14].
Systematic genetic studies of C. elegans have provided more
direct evidence that proteases comprise the effector arm of
the cell death pathway. Two genes, ced-3 and ced-4, are
required for all somatic cell deaths that occur during nema-
tode development [15]. Mutations of ced-3 and ced-4 abolish
the apoptotic capability of cells that would otherwise be
destined to die during C. elegans embryogenesis [16]. No
homologs of the CED-4 protein have yet been identified,
but numerous relatives of CED-3 have been characterized
and comprise a new family of cysteine proteases. 
The first mammalian homolog of CED-3 identified was
interleukin-1b (IL-1b) converting enzyme (ICE), a cys-
teine protease responsible for the processing of pro-IL-1b
to the active cytokine [17]. Like granzyme B, ICE has the
unusual property of cleaving after aspartate residues [18].
Overexpression of ICE or CED-3 in Rat-1 fibroblasts
induces apoptosis, suggesting that ICE is functionally, as
well as structurally, related to CED-3 [19]. However, such
evidence is not conclusive, as ectopic expression of a
number of proteases including chymotrypsin, proteinase K
and trypsin cause significant apoptosis [20].
Subsequent studies have suggested that proteases related
to ICE might be more important than ICE itself in the
apoptotic mechanism. First, a number of cell types stably
secrete mature IL-1b without undergoing apoptosis.
Second, ICE-deficient mice, although unable to generate
active IL-1b, do not have any obvious defects in apoptosis,
except possibly in the apoptotic pathway induced by
engagement of the cell-surface receptor Fas/APO-1
[21,22]. Third, in an in vitro model of apoptosis, extracts
prepared from chicken DU249 cells failed to cleave the
primary substrate of ICE, pro-IL-1b [23]; instead, a proteo-
lytic activity in these extracts, termed prICE, cleaved the
well-characterized ‘death substrate’ poly (ADP-ribose)
polymerase (PARP) into fragments characteristic of apop-
tosis [23]. Purified ICE failed to cleave PARP [23,24],
suggesting that prICE is distinct from ICE.
To date, six mammalian homologs of CED-3 and ICE
have been characterized, including Nedd-2/ICH1 [25,26],
Yama/CPP32/apopain [24,27,28], Tx/ICH2/ICE rel-II
[29–31], ICE rel-III [29], Mch2 [32], and ICE-LAP3/
Mch3/CMH-1 [33–35]. On the basis of searches of the
‘expressed sequence tagged’ (EST) database of sequences
from expressed human genes (C. Vincenz, H. Duan,
V.M.D., unpublished observation), there are at least three
additional mammalian ICE/CED-3 homologs. Three sub-
families of the ICE/CED-3 family have been defined (Fig.
1): Yama, ICE-LAP3, and Mch2 are closely related to C.
elegans CED-3 and comprise the CED-3 subfamily; ICE,
ICE rel II and ICE rel III form the ICE subfamily; and
ICH1 and its mouse homologue, NEDD-2, form the
NEDD-2 subfamily. All family members so far character-
ized contain an active site QACRG pentapeptide and are
expressed in a broad range of tissues, developmental stages
and cell lines. Ectopic expression of these ICE/CED-3
homologs in a variety of cells causes apoptosis.
An important advance came with the discovery that Yama,
unlike ICE, efficiently cleaves the death substrate PARP
into fragments characteristic of apoptosis [24,28]. Acti-
vated Yama was biochemically purified from THP-1 cells
using the Ac-DEVD-CHO tetrapeptide aldehyde corres-
ponding to the amino acids of the PARP cleavage site [28].
This peptide was used to remove active Yama, and pre-
sumably other Yama-like proteases, from apoptotic
osteosarcoma cell extracts, abrogating their apoptotic
potential in vitro. This apoptotic activity could be restored
by adding back purified Yama to the depleted extracts
[28]. Taken together, these observations suggest that
Yama may be the physiological PARP-cleaving enzyme
(prICE), and may serve as the mammalian equivalent of
CED-3.
Soon after these results on Yama came the discovery that
Mch2 and ICE-LAP3 also cleave PARP efficiently
[32,34,35]. Interestingly, both proteases are in the same
subfamily — the CED-3 subfamily — as Yama (Fig. 1).
Furthermore, ICE-LAP3 is inhibited by the Ac-DEVD-
CHO tetrapeptide aldehyde with similar kinetics to those
shown by Yama [34,35]. Thus, the PARP-cleavage activity
of apoptotic cells (prICE) may actually be carried out by
more than one ICE-like protease, suggesting redundancy
in the cell-death pathway. As expected, CED-3 was
shown to function as a cysteine protease [36,37]. Like
Yama and ICE-LAP3, CED-3 cleaves PARP more
efficiently than it cleaves pro-IL-1b, and it is also
inhibited by Ac-DEVD-CHO [37].
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Figure 1
Phylogenetic analysis of the ICE/CED-3 family of cysteine proteases,
which can be subdivided into three groups. Sequences were aligned
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If members of the ICE/CED-3 family are involved in the
cell-death pathway, they should be activated by apoptotic
death stimuli. Like the family prototype, ICE, other
members of the ICE/CED-3 family are synthesized as
proenzymes which are proteolytically processed to form
active heterodimeric enzymes [18]. Yama is expressed as a
32 kDa precursor, and upon activation it is processed into
p17 and p12 subunits [28]. As predicted, Yama is activated
upon receipt of various apoptotic stimuli, such as engage-
ment of the Fas/APO-1 receptor [38,39], or treatment with
the broad-spectrum protein kinase inhibitor staurosporine
[38]. Furthermore, granzyme B can directly activate Yama,
suggesting a potential mechanism for cytotoxic T-cell-
induced apoptosis [40,41]. Like Yama, ICE-LAP3 and
Mch2 are activated by a variety of apoptotic stimuli
([33,38] and K. Orth, personal communication), implying
that the ICE-like proteases most related to CED-3 (Fig. 1)
are important components of the cell-death machinery
(Fig. 2). Thus, mammals, unlike the nematode, may
possess an arsenal of CED-3-like proteases able to trans-
mit the death signal. These apoptotic proteases may each
cleave a specific ‘death substrate’, form redundant path-
ways or comprise a proteolytic cascade.
Given that mammalian CED-3 homologs are apoptotic
effectors, what are their substrates? Importantly, which
substrates must be cleaved to drive cells into apoptosis? As
discussed earlier, PARP, one of the best-characterized
death substrates, is cleaved during many, if not all, forms
of apoptosis [24,42]. Cleavage of PARP is probably not
directly important in the cell-death mechanism, as PARP-
deficient mice develop normally and do not show signifi-
cant perturbations of apoptosis [43]. The list of death
substrates and potential targets for ICE-like proteases is
growing and includes the nuclear lamins [44,45], the
70 kDa component of U1 small nuclear ribonucleoprotein
(U1-70 kDa snRNP) [46,47], D4 guanine nucleotide dis-
sociation inhibitor (D4-GDI) [48], sterol regulatory
element binding proteins (SREBPs) [49] and protein
kinase C d (PKCd) [50]. It is not yet clear whether the
cleavage of any of these substrates is important in the
execution phase of apoptosis. 
As mentioned, profound morphological alterations of the
nucleus are a hallmark of apoptosis, and ICE-like pro-
teases may have an important role here. The nuclear
lamins are cleaved early during apoptosis [45]. Lamins are
intermediate filament proteins that provide a structural
framework for the inner nuclear membrane. Recent
studies suggest that an ICE-like enzyme distinct from
Yama/CPP32 may be responsible for lamin proteolysis
[44]. Incubation with the ICE inhibitor YVAD
chloromethyl ketone blocked lamin cleavage, PARP
cleavage and DNA fragmentation in nuclei added to apop-
totic cell extracts. Interestingly, only lamin cleavage was
susceptible to inhibition by tosyl-L-lysl chloromethyl
ketone (TLCK) [44]. This selective inhibition also par-
tially blocked the morphologic transformation of added
nuclei [44]. These observations provide further evidence
for the involvement of multiple ICE/CED-3 family
members in the apoptotic mechanism (Fig. 2).
What is the subcellular localization of ICE/CED-3 family
members? Enucleated cells treated with various death
stimuli undergo the morphological changes associated
with apoptosis, suggesting the cell-death machinery
resides outside the nucleus [51,52]. Indeed, pro-Yama and
pro-ICE-LAP3 have been localized to the cell cytoplasm
([33] and our unpublished observation). By contrast, active
ICE localizes to the external surfaces of the plasma mem-
brane, further emphasizing the role of ICE in IL-1b pro-
cessing and secretion rather than apoptosis [53]. But if the
cell-death machinery is cytoplasmic, it is unclear how it
gains access to the nucleus to initiate DNA fragmentation,
chromatin condensation and the cleavage of several
nuclear death substrates, including PARP, U1-70 kDa and
the nuclear lamins. Interestingly, active granzyme B has
been localized to the nucleus [54]. It will be important to
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Figure 2
The cell-death machinery. Apoptotic stimuli lead to the processing of
CED-3-like apoptotic proteases, generating their active, heterodimeric
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determine whether the processed, active apoptotic pro-
teases have access to the nucleus.
Braking cell death
The C. elegans model system has also provided insight into
the negative regulators of the cell-death pathway (Table
1). The ced-9 gene antagonizes the function of ced-3 and
ced-4 by blocking cell death [55]. Importantly, CED-9 is
homologous to Bcl-2, the prototypic member of a growing
family of cell-death regulators [56]. First identified for its
role in B-cell malignancies, bcl-2 when overexpressed
inhibits cell death induced by a variety of apoptotic
stimuli and in numerous cell types [57]. The fact that bcl-2
can substitute functionally for ced-9, preventing cell death
in the nematode, further emphasizes the highly conserved
nature of the cell-death machinery [56].
The Bcl-2 family is comprised of both inhibitors of cell
death, such as Bcl-2 and Bcl-xL, and promoters of cell
death, such as Bax and Bak [9,58,59]. The question of how
the negative regulators Bcl-2 and Bcl-xL function relative to
the death-promoting members of the Bcl-2 family is a con-
troversial one. Importantly, Bcl-2 family members can form
homodimers and heterodimers [59,60]. It was originally
proposed that Bax (and presumably Bak) directly engages
the cell-death machinery, whereas Bcl-2 and Bcl-xL merely
antagonize this interaction [61]. Supporting this contention,
mutant forms of Bcl-2 that fail to heterodimerize with Bax
and Bak lose their ability to protect cells from apoptosis
[61]. Recently, however, Cheng et al. [62] have identified
mutant forms of Bcl-xL that fail to interact with Bax or Bak,
but still maintain death-inhibiting activity, arguing for the
existence of a Bax/Bak-independent cell-death pathway.
These recent findings would support a model in which Bax
and Bak promote cell death by sequestering Bcl-2 and
Bcl-xL, preventing these negative regulators from binding
and inhibiting their intended target.
Where do Bcl-2 and CED-9 function relative to members
of the CED-3 family? Genetic evidence in C. elegans sug-
gests that CED-9 functions upstream of the death effectors
CED-3 and CED-4, preventing their activation [63,64].
The molecular order of the cell-death pathway has been
confirmed biochemically in mammalian cells [38]. It was
demonstrated that Bcl-2 and Bcl-xL prevent the proteolytic
activation of the mammalian CED-3 homologs Yama, ICE-
LAP3 and Mch2 ([38], and A.M.C., unpublished data),
suggesting that Bcl-2/Bcl-xL function upstream of the
apoptotic proteases (Fig. 3). Molecular ordering of the cell-
death pathway will hopefully help explain how members
of the Bcl-2 family function.
Other negative regulators of cell death have been discov-
ered in the course of research on viruses. It is not surpris-
ing that viruses have mastered the art of keeping cells
alive, for it is in their interest to maintain the cell ‘factories’
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Figure 3
Regulation of the mammalian CED-3 homologs. The apoptotic activator
shown is a death-domain protein functionally related to Drosophila
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Table 1
Negative regulators of the cell-death pathway.
Protein Function
CED-9 Important inhibitor of cell death in C. elegans, 
homologous to Bcl-2 [55,56].
Bcl-2 family Some family members, such as Bcl-2 and Bcl-xL, 
inhibit cell death, whereas others, such as Bax and
Bak, promote cell death [9,58,59]
p35 Baculovirus protein that inhibits cell death in mammals, 
insects and nematodes. Its target is likely ICE/CED-3 
family members [36,81,83] 
CrmA (SPI-2) Cowpox serpin that inhibits ICE, ICE-like proteins and
granzyme B. Can block apoptosis induced by growth 
factor withdrawal [72], TNF [73], Fas [73–75], and 
poxvirus infection [71].
SPI-1 A poxvirus serpin likely having an enzyme specificity
distinct from CrmA; inhibits poxvirus-induced apoptosis 
[71].
IAP family Inhibitors of apoptosis; baculovirus, Drosophila and 
human homologs identified [82,85,86].
NAIP Inhibitor of cell death induced by various apoptotic
stimuli, including TNF; product of candidate gene
responsible for spinal muscular atrophy, and related
to IAPs [86,88].
Dad1 Protein that inhibits cell death; mammalian and
C. elegans homologs identified [110,111].
A20 Mammalian protein that inhibits TNF-induced apoptosis
but not Fas-induced apoptosis [112,113].
that produce their progeny. Viral counterparts of Bcl-2
include the adenovirus protein E1B-19 kDa [65,66] and
the Epstein Barr virus protein BHRF-1 [67]. Expression of
Bcl-2 or E1B-19 kDa inhibits Yama activation and apopto-
sis induced by E1A [68]. Proteins unrelated to Bcl-2 that
inhibit cell death and are harbored by viruses include
CrmA, p35 and the IAPs.
CrmA is a cowpox serpin that inhibits ICE-like proteases
and granzyme B [24,69,70]. However, ICE is inhibited by
CrmA at much lower concentrations than is Yama, ICE-
LAP3 or granzyme B [28,34]. CrmA blocks cell death
induced by viral infection [71], growth-factor withdrawal
[72], treatment with tumor necrosis factor (TNF) [73] and
engagement of Fas/APO-1 [73–75]. When CrmA-express-
ing cells are treated with anti-Fas antibody, both Yama
and ICE-LAP3 remain as inactive pre-enzymes, suggest-
ing that CrmA inhibits an ICE-like enzyme upstream of
Yama and ICE-LAP3 [38]. This hypothesis is especially
attractive considering that ICE has been shown to process
Yama into active subunits [24]. The role of ICE in the
Fas pathway is supported by the observation that thymo-
cytes from ICE-deficient mice are resistant to Fas-
induced cell death [22]. Significantly, however, ICE-
deficient mice do not exhibit the lymphoproliferative
phenotype [21,22] characteristic of mice that carrying a
defect in the fas gene [76]. We postulate that ICE, or
more likely a member of the ICE subfamily (Fig. 1), acts
as the CrmA target and functions upstream of Yama and
the Yama-related proteases (Fig. 2).
Baculovirus p35 is another viral inhibitor of apoptosis and
is remarkable in that it can block cell death in mammals,
insects and nematodes, suggesting that its target of action
is evolutionarily conserved [77–80]. Recent studies
suggest that p35 functions by directly inhibiting
ICE/CED-3 family members [36,81]. Although p35 is
specifically cleaved by ICE-like proteases, its mechanism
of action is unclear. Unlike CrmA, p35 is not related to the
serpin family of protease inhibitors. It is not yet known
whether one or more ICE/CED-3 family members are
targeted by p35 in mammalian cells.
The inhibitors of apoptosis — IAPs — constitute another
family of cell-death suppressors that have been abducted
by viruses [82,83]. Like p35, viral IAPs (from Orgyia
pseudotsugata and Cydia pomonella granulosis) block cell
death induced by baculovirus infection and other apop-
totic stimuli [82–84], but their mechanism of action is not
known. Recently, cellular homologs of the viral IAPs have
been identified in Drosophila and in mammals. In
Drosophila, DIAP1 was identified in a search for mutations
that enhance cell death triggered by the reaper gene (see
below), whereas DIAP2 was identified by a subsequent
Genbank search [85,86]. Transgenic flies expressing the
Drosophila IAPs are partially protected from cell death [85]. 
Mammalian homologs of the IAPs have recently been
identified by two groups. Rothe et al. [87] showed that
c-IAP1 and c-IAP2 are components of the tumor necrosis
factor receptor-2 (TNFR-2) signalling complex, which
includes two TNFR-associated factors (TRAF1 and
TRAF2). By searching the Genbank database, Liston et al.
[86] isolated the genes for the same IAPs, along with an
additional mammalian IAP family member, xIAP. Impor-
tantly, these mammalian IAPs inhibit cell death induced
by a number of apoptotic stimuli [86]. The baculoviral
inhibition of apoptosis protein repeat (BIR) domain,
which is the motif most conserved among species, likely
mediates the inhibition of cell death by the IAPs [82].
The gene encoding NAIP, a protein with homology to the
IAPs, was shown to be partially deleted in individuals with
spinal muscular atrophy (SMA), a common fatal autosomal
recessive disorder [88]. It has been postulated that SMA is
caused by inappropriate motor neuron apoptosis resulting
from the absence of a functional cell-death inhibitor. Con-
sistent with this hypothesis, overexpression of NAIP
inhibits apoptosis induced by a variety of stimuli [86]. The
human IAPs and NAIP are emerging as a new class of
endogenous mammalian cell-death suppressors, an area
previously monopolized by the Bcl-2 family. Future studies
will hopefully determine how the IAPs function relative to
the apoptotic proteases of the ICE/CED-3 family.
Igniting apoptosis
Studies of C. elegans have provided insights into the effec-
tors and the negative regulators — the ‘engine’ and
‘brakes’, respectively — of the cell-death machine.
Another invertebrate, Drosophila melanogaster, has been
useful in understanding how a dormant cell-death machine
may be activated [89]. Genetic analyses of Drosophila have
identified a gene, reaper, important in triggering the apop-
totic program [89]. The reaper gene encodes a 65-residue
polypeptide that is upregulated during Drosophila cell
death [89]. It is unlikely that reaper is a death effector, as
reaper-deficient embryos, although less sensitive to death
stimuli, still undergo apoptosis [90]. In addition, recent
studies suggest that reaper functions as an upstream activa-
tor of ICE/CED-3 homologs [80,91]. Transgenic flies
expressing reaper, under the control of an inducible pro-
moter, are protected from cell death by overexpression of
the baculovirus protein p35 [80,85], which is thought to
target ICE-like proteases. Furthermore, reaper-induced
death of Drosophila Schneider cells can be inhibited by the
broad-spectrum ICE-inhibitor, N-benzyloxycarbonyl-Val-
Ala-Asp-fluoromethylketone (z-VAD-FMK) [91]. Interest-
ingly, a Drosophila ICE/CED-3 homolog has recently been
identified in the Genbank database [7].
Although no mammalian equivalent of reaper has yet been
identified, Reaper shows weak homology to the so-called
‘death domain’ of certain mammalian proteins [92]. The
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death domain was first characterized as a region of homol-
ogy of about 70 amino acids in the 55 kDa TNFR-1 and
Fas/APO-1 [93,94]. TNFR-1 and Fas/APO-1 are type I
transmembrane proteins [95,96], and their activation is
caused by aggregation mediated by the respective ligands
or by agonist antibodies [97–99]. The death domains of
TNFR-1 and Fas/APO-1 are required for these receptors
to activate the apoptotic program [93,94]. The apoptotic
signal is thought to be transduced by clustering of death
domains [100]. Although reaper must be transcriptionally
up-regulated to signal death, subsequent oligomerization
may also play a role [89]. Like Reaper-induced cell death,
cell death induced by TNFR-1 and Fas/APO-1 is blocked
by p35 [101] and z-VAD-FMK (our unpublished observa-
tion), implicating ICE/CED-3 homologs in both death
pathways. An attractive hypothesis is that Fas/APO-1 and
TNFR-1 are chimeric molecules evolved from the linkage
of a Reaper-like motif to an extracellular domain, allowing
for direct activation of the cell-death machinery by
cytokines [92]. 
Reaper is also weakly homologous to FADD and TRADD,
the intracellular signaling molecules used by Fas/APO-1
and TNFR-1, respectively (reviewed in [102,103]).
Both FADD and TRADD contain death domains and,
on overexpression, they activate the death pathway
[104–106]. Endogenous FADD and TRADD associate
with their respective receptors in a ligand-dependent
fashion [107,108]. It has been postulated that TRADD
acts as an adaptor molecule that mediates the interaction
of TNFR-1 with FADD [107]. A dominant-negative
version of FADD blocks TNF- and Fas/APO-1-induced
apoptosis, suggesting that FADD acts as the common
conduit for cytokine-mediated cell death [107,109]. An
intriguing possibility is that, because of its similar
sequence, function, and cell autonomy, Reaper may repre-
sent an ancestral form of FADD and TRADD. One might
speculate that the dominant negative version of FADD
would block Reaper-induced cell death, suggesting that
the cell-death machine is activated or ‘ignited’ in a similar
way in mammals and Drosophila.
Conclusions
Identification of the genes that regulate cell death has pro-
pelled the study of apoptosis to the forefront of biomedical
research. Components of the cell-death pathway are likely
conserved through the evolution of multicellular organ-
isms. Invertebrate model systems have played an impor-
tant part in the identification of several cell-death genes,
but it is becoming apparent that the cell-death machinery
in mammals may be more complex because of redundancy.
For example, mammalian homologs of ced-9 include bcl-2,
bcl-xL, bax and bak. Similarly, a family of novel and diverse
cysteine proteases related to the death effector ced-3 have
been identified, a subset of which is likely to have an
important role in the apoptotic mechanism. The cell-death
machine is composed of a number of parts (or gene prod-
ucts), including activators, effectors and negative regula-
tors. Discovering how the individual components interact
is breathing new life into the study of cell death.
Acknowledgments
We would like to thank the members of the Dixit lab for critical review of the
manuscript and Ian Jones for helping prepare the figures. A.M.C. is a fellow
of the Medical Scientist Training Program supported by an Experimental
Immunopathology Grant. 
References
1. Raff MC: Social controls on cell survival and cell death. Nature
1992, 356:397–400.
2. Cohen JJ: Apoptosis. Immunology Today 1993, 14:126–130.
3. Peitsch MC, Mannherz HG, Tschopp J: The apoptosis
endonucleases: cleaning up after cell death? Trends Cell Biol
1994, 4:37–41.
4. Majno G, Joris I: Apoptosis, oncosis, and necrosis. Am J Pathol
1995, 146:3–15.
5. Thompson CB: Apoptosis in the pathogenesis and treatment of
Disease. Science 1995, 267:1456–1462.
6. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on
apoptosis. Cell 1994, 76:777–779.
7. Hengartner MO: Programmed cell death in invertebrates. Curr
Opin Gen Dev 1996, 6:34–38.
8. Evan GI, Brown L, Whyte M, Harrington E: Apoptosis and cell cycle.
Curr Opin Cell Biol 1995, 7:825–836.
9. White E: Life, death, and the pursuit of apoptosis. Genes Dev
1996, 10:1–15.
10. Martin SJ, Green DR: Protease activation during apoptosis: death
by a thousand cuts? Cell 1995, 82:349–352.
11. Kumar S, Harvey NL: Role of multiple cellular proteases in the
execution of programmed cell death. FEBS Lett 1995, 375:169–173.
12. Heusel JW, Wesseischmidt RL, Shresta S, Russel JH, Ley TJ:
Cytotoxic lymphocytes require granzyme B for the rapid induction
of DNA fragmentation and apoptosis in allogeneic target cells.
Cell 1994, 76:977–987.
13. Smyth MJ, Trapani JA: Granzymes: exogenous proteinases that
induce target cell apoptosis. Immunology Today 1995, 16:202–206.
14. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH: Purification
of three cytotoxic lymphocyte granule serine proteases. J Exp
Med 1992, 176:1521–1529.
15. Ellis HM, Horvitz HR: Genetic control of programmed cell death in
the nematode Caenorhabditis elegans. Cell 1986, 44:817–829.
16. Yuan JY, Horvitz HR: The Caenorhabditis elegans genes ced-3 and
ced-4 act cell autonomously to cause programmed cell death.
Dev Biol 1990, 138:33–41.
17. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans
cell death gene ced-3 encodes a protein similar to mammalian
interleukin-1ß-converting enzyme. Cell 1993, 75:641–652.
18. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD,
Kostura MJ, et al.: A novel heterodimeric cysteine protease is
required for interleukin-1ß processing in monocytes. Nature 1992,
356:768–774.
19. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of
apoptosis in fibroblasts by IL-1ß converting enzyme, a
mammalian homolog of the C. elegans cell death gene ced-3. Cell
1993, 75:653–660.
20. Williams MS, Henkart PA: Apoptotic cell death induced by
intracellular proteolysis. J Immunol 1994, 1994:4247–4255.
21. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al.:
Mice deficient in IL-1ß-converting enzyme are defective in
production of mature IL-1ß and resistant to endotoxic shock. Cell
1995, 80:401–411.
22. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MSS, et al.:
Altered cytokine export and apoptosis in mice deficient in
interleukin-1ß converting enzyme. Science 1995, 267:2000–2003.
23. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC:
Cleavage of poly(ADP-ribose) polymerase by a proteinase with
properties like ICE. Nature 1994, 371:346–347.
24. Tewari M, Quan LT, O’Rourke K, Desnoyers S, Zeng Z, Beidler DR, et
al.: Yama/CPP32ß, a mammalian homolog of CED-3, is a CrmA-
inhibitable protease that cleaves the death substrate poly(ADP-
ribose) polymerase. Cell 1995, 81:801–809.
560 Current Biology 1996, Vol 6 No 5
25. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction
of apoptosis by the mouse Nedd2 gene, which encodes a protein
similar to the product of the Caenorhabditis elegans cell death
gene ced-3 and the mammalian IL-1ß-converting enzyme. Genes
Dev 1994, 8:1613–1626.
26. Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an ICE/ced-3-
related gene, encodes both positive and negative regulators of
programmed cell death. Cell 1994, 78:739–750.
27. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human
apoptotic protein with homology to Caenorhabditis elegans cell
death protein CED-3 and mammalian interleukin-1ß-converting
enzyme. J Biol Chem 1994, 269:30761–30764.
28. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant
M, et al.: Identification and inhibition of the ICE/CED-3 protease
necessary for mammalian apoptosis. Nature 1995, 376:37–43.
29. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux
SM, et al.: Molecular cloning and pro-apoptotic activity of ICErel II
and ICErel III, members of the ICE/CED-3 family of cysteine
proteases. J Biol Chem 1995, 270:15870–15876.
30. Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Herve F, et
al.: A novel human protease similar to the interleukin-1 beta
converting enzyme induces apoptosis in transfected cells. EMBO
J 1995, 14:1914–1922.
31. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, et
al.: Identification and characterization of ICH-2, a novel member
of the interleukin-1 beta-converting enzyme family of cysteine
proteases. J Biol Chem 1995, 270:15250–15256.
32. Fernandes-Alnemri T, Litwack G, Alnemri ES: Mch2, a new member
of the apoptotic CED-3/ICE cysteine protease gene family.
Cancer Res 1995, 55:2737–2742.
33. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W, Dixit VM: ICE-
LAP3, a novel mammalian homolog of the Caenorhabditis elegans
cell death protein CED-3 is activated during Fas- and tumor
necrosis factor-Induced apoptosis. J Biol Chem 1996,
271:1621–1625.
34. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L,
Tomaselli KJ, et al.: Mch3, a novel human apoptotic cysteine
protease highly related to CPP32. Cancer Res 1995, 55:6045–6052.
35. Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MS-S: Identification and
characterization of CPP32/Mch2 homolog 1, a novel cysteine
protease similar to CPP32. J Biol Chem 1996, 271:1825–1828.
36. Xue D, Horvitz HR: Inhibition of the Caenorhabditis elegans cell
death protease CED-3 by a CED-3 cleavage site in baculovirus
p35 protein. Nature 1995, 377:248–251.
37. Hugunin M, Quintal LJ, Mankovich JA, Ghayur T: Protease activity of
in vitro transcribed and translated Caenorhabditis elegans cell
death gene (ced-3) product. J Biol Chem 1996, 271:3517–3522.
38. Chinnaiyan AM, Orth K, O’Rourke K, Duan H, Poirier GG, Dixit VM:
Molecular ordering of the cell death pathway: Bcl-2 and BclxL
function upstream of the CED-3-like apoptotic proteases. J Biol
Chem 1996, 271:4573–4576.
39. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T-T,
et al.: CPP32/Apopain is the key interleukin-1b converting
enzyme-like protease involved in Fas-mediated apoptosis. J Biol
Chem 1996, 271:1841–1844.
40. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the
apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme
B. Nature 1995, 377:446–448.
41. Quan LT, Tewari M, O’Rourke K, Dixit VM, Snipas SJ, Poirier GG, et
al.: Proteolytic activation of the cell death protease Yama/CPP32
by granzyme B. Proc Natl Acad Sci USA 1996, 93:1972–1976.
42. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG:
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an
early marker of chemotherapy-induced apoptosis. Cancer Res
1993, 53:3976–3985.
43. Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger
M, et al.: Mice lacking ADPRT and poly(ADP-ribosyl)ation develop
normally but are susceptible to skin disease. Genes Dev 1995,
9:509–520.
44. Lazebnik YA, Takahashi A, Moir R, Goldman R, Poirier GG, Kaufmann
SH, et al.: Studies of the lamin proteinase reveal multiple parallel
biochemical pathways during apoptotic execution. Proc Natl Acad
Sci USA 1995, 92:9042–9046.
45. Neamati N, Fernandez A, Wright S, Kiefer J, McConkey DJ:
Degradation of lamin B1 precedes oligonucleosomal DNA
fragmentation in apoptotic thymocytes and isolated thymocyte
nuclei. J Immunol 1994, 154:1693–1700.
46. Tewari M, Beidler DR, Dixit VM: CrmA-inhibitable cleavage of the
70 kDa protein component of the U1 small nuclear
ribonucleoprotein during Fas- and tumor necrosis factor-induced
apoptosis. J Biol Chem 1995, 270:18738–18741.
47. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A: Specific
cleavage of the 70-kDa protein component of small
nuclear ribonucleoprotein is a characteristic biochemical
feature of apoptotic cell death. J Biol Chem 1994,
269:30757–30760.
48. Na S, Chuang RH, Turi TG, Hanke JH, Bokoch GM, Danley DE: D4-
GDI, a substrate for CPP32, is proteolyzed during Fas-induced
apoptosis. J Biol Chem 1996, 271: in press.
49. Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL:
Cleavage of the sterol regulatory element binding proteins
(SREBPs) by CPP32 during apoptosis. EMBO J 1996,
15:1012–1020
50. Emoto Y, Manome Y, Meinhardt G, Ghayur T, Wong WW, Kamen R,
et al.: Proteolytic activation of protein kinase C d an ICE-like
protease in apoptotic cells. EMBO J 1995, 14:6148–6156.
51. Jacobson MD, Burne JF, Raff MC: Programmed cell death and
Bcl-2 protection in the absence of a nucleus. EMBO J 1994,
13:1899–910.
52. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH: Cell nucleus
and DNA fragmentation are not required for apoptosis. J Cell Biol
1994, 127:15–20.
53. Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, et al.: The
interleukin-1b converting enzyme (ICE) is localized on the
external cell surface membranes and in the cytoplasmic ground
substance of human monocytes by immuno-electron microscopy.
J Exp Med 1995, 182:1447–1459.
54. Trapani JA, Browne KA, Smyth MJ, Jans DA: Localization of
granzyme B in the nucleus. J Biol Chem1996, 271:4127–4133.
55. Hengartner MO, Ellis RE, Horvitz HR: Caenorhabditis elegans gene
ced-9 protects cells from programmed cell death. Nature 1992,
356:494–499.
56. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9
encodes a functional homolog of the mammalian protooncogene
bcl-2. Cell 1994, 76:665–676.
57. Reed JC: Bcl-2 and the regulation of programmed cell death. J
Cell Biol 1994, 124:1–6.
58. Nunez G, Clarke MF: The Bcl-2 family of proteins: regulators of cell
death and survival. Trends Cell Biol 1994, 4:399–403.
59. Farrow SN, Brown R: New members of the Bcl-2 family and their
protein partners. Curr Opin Gen Dev 1996, 6:45–49.
60. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, et
al.: Multiple Bcl-2 family members demonstrate selective
dimerizations with Bax. Proc Natl Acad Sci USA 1995,
92:7834–7838.
61. Oltavai ZN, Millian CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo
with a conserved homolog, BAX, that accelerates programmed
cell death. Cell 1993, 74:609–619.
62. Cheng EH-Y, Levine B, Boise LH, Thompson CB, Hardwick M: Bax-
independent inhibition of apoptosis by Bcl-xL. Nature 1996,
379:554–556.
63. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell
death. Ann Rev Cell Biol 1991, 7:663–698.
64. Hengartner MO, Horvitz HR: The ins and outs of programmed cell
death during C. elegans development. Philos Trans R Soc Lond B
Biol Sci 1994, 345:243–246.
65. White E: Function of the adenovirus E1B oncogene in infected
and transformed cells. In Seminars in Virology. Edited by Fanning E.
London: Academic Press; 1994:341–348.
66. Boyd J, Malstrom S, Subramanian T, Venkatesh L, Schaeper U,
Elangovan B, et al.: Adenovirus E1B 19 kDa and Bcl-2 proteins
interact with a common set of cellular proteins. Cell 1994,
79:341–351.
67. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A:
Epstein-Barr virus-coded BHRF1 protein, a viral homologue of
bcl-2, protects human B cells from programmed cell death. Proc
Natl Acad Sci, USA 1993, 90:8479–8483.
68. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson
DW, et al.: Bcl-2 and adenovirus E1B 19kDa protein prevent E1A-
induced processing of CPP32 and cleavage of poly(ADP-ribose)
polymerase. Oncogene 1996, 12: in press.
69. Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS:
Granzyme is inhibited by the cowpox virus serpin cytokine
response modifier A. J Biol Chem 1995, 270:10377–10379.
Review  Regulation of cell death  561
70. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR,
Salvesen GS, et al.: Viral inhibition of inflammation: cowpox virus
encodes an inhibitor of the Interleukin-1ß converting enzyme. Cell
1992, 69:597–604.
71. Brooks MA, Ali AN, Turner PC, Moyer RW: A rabbit virus serpin
gene controls host range by inhibiting apoptosis in restrictive
cells. J Virol 1995, 69:7688–7698.
72. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ,
Fishman MC, et al.: Prevention of vertebrate neuronal death by the
crmA gene. Science 1994, 263:826–828.
73. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced
apoptosis is inhibited by the poxvirus crmA gene product. J Biol
Chem 1995, 270:3255–3260.
74. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M,
Baeuerle PA, et al.: Requirement of an ICE/CED-3 protease for
Fas/APO-1-mediated apoptosis. Nature 1995, 375:81–83.
75. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in
Fas-mediated apoptosis. Nature 1995, 375:78–81.
76. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations.
Immunol Today 1995, 16:39–43.
77. Rabizadeh S, LaCount DJ, Friesen PD, Bredesen DE: Expression of
the baculovirus p35 gene inhibits mammalian neural cell death. J
Neurochem 1993, 61:2318–2321.
78. Martinou I, Fernandez PA, Missotten M, White E, Allet B, Sadoul R, et
al.: Viral proteins E1B19K and p35 protect sympathetic neurons
from cell death induced by NGF deprivation. J Cell Biol 1995,
128:201–208.
79. Sugimoto A, Friesen PD, Rothman JH: Baculovirus p35 prevents
developmentally programmed cell death and rescues a ced-9
mutant in the nematode Caenorhabditis elegans. EMBO J 1994,
13:2023–2028.
80. White K, Tahaoglu E, Steller H: Cell killing the Drosophila gene
reaper. Science 1996, 271:805–807.
81. Bump NJ, Hackett M, Huginin M, Sheshagiri S, Brady K, Chen P, et
al.: Inhibition of ICE family proteases by baculovirus antiapoptotic
protein p35. Science 1995, 269:1885–1888.
82. Clem RJ, Miller LK: Control of programmed cell death by the
baculovirus genes p35 and iap. Mol Cell Biol 1994, 14:5212–22.
83. Clem RJ, Miller LK. (1994). Induction and inhibition of apoptosis by
insect viruses. In Apoptosis II: The Molecular Basis of Apoptosis in
Disease. Edited by Tomei DL, Cope FO. Cold Spring Harbor: Cold
Spring Harbor Press; 1994:89–110.
84. Clem RJ, Fechheimer M, Miller LK: Prevention of apoptosis by a
baculovirus gene during infection of insect cells. Science 1991,
254:1388–1390.
85. Hay BA, Wassarman DA, Rubin GM: Drosophila homologs of
baculovirus inhibitor of apoptosis proteins function to block cell
death. Cell 1995, 83:1253–1262.
86. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, ChertonHorvat G, et
al.: Suppression of apoptosis in mammalian cells by NAIP and a
related family of IAP genes. Nature 1996, 349–352.
87. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV: The TNFR2-
TRAF signaling complex contains two novel proteins related to
baculoviral inhibitor of apoptosis proteins. Cell 1995,
83:1243–1252.
88. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R,
et al.: The gene for neuronal apoptosis inhibitory protein is
partially deleted in individuals with spinal muscular atrophy. Cell
1995, 80:167–178.
89. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H:
Genetic control of programmed cell death in Drosophila. Science
1994, 264:677–683.
90. Steller H: Mechanisms and genes of cellular suicide. Science
1995, 267:1445–1449.
91. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like
protease for induction of apoptosis and ceramide generation by
Reaper. Science 1996, 271:808–810.
92. Golstein P, Marguet D, Depraetere V: Homology between Reaper
and the cell death domains of Fas and TNFR1 [letter]. Cell 1995,
81:185–186.
93. Itoh N, Nagata S: A novel protein domain required for apoptosis.
Mutational analysis of human Fas antigen. J Biol Chem 1993,
268:10932–10937.
94. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV: A novel domain
within the 55 kd TNF receptor signals cell death. Cell 1993,
74:845–853.
95. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, et al.:
A receptor for tumor necrosis factor defines an unusual family of
cellular and viral proteins. Science 1990, 248:1019–1023.
96. Tewari M, Dixit VM: Signalling through members of the tumor
necrosis receptor family. In Modular Texts in Molecular and Cell
Biology. Edited by Purton M, Heldin C. London: Chapman and Hall; in
press.
97. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH:
Induction of apoptosis by monoclonal antibody anti-APO-1 class
switch variants is dependent on cross-linking of APO-1 cell
surface antigens. J Immunol 1992, 149:3166–3173.
98. Baglioni C: Mechanisms of cytotoxicity, cytolysis, and growth
stimulation by TNF. In Tumor Necrosis Factors. The Molecules and
their Emerging Role in Medicine. Edited by Beutler B. New York:
Raven Press; 1992:425–438.
99. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima
M, et al.: The polypeptide encoded by the cDNA for human cell
surface antigen Fas can mediate apoptosis. Cell 1991,
66:233–243.
100. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y,
Camonis JH, et al.: Self-association of the “death domains” of the
p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts
signaling for TNF and Fas/APO1 effects. J Biol Chem 1995,
270:387–391.
101. Beidler DR, Tewari MT, Friesen PD, Poirier G, Dixit VM: The
baculovirus p35 protein inhibits Fas- and Tumor Necrosis Factor-
induced apoptosis. J Biol Chem 1995, 270:16526–16528.
102. Cleveland JL, Ihle JN: Contenders in FasL/TNF signaling. Cell 1995,
81:479–482.
103. Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan AM, Krammer PH,
Dixit VM: CD95 (APO-1/Fas)-associating signaling proteins. Cell
Death Diff 1996, 3:161–170.
104. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated
protein TRADD signals cell death and NF- kappa B activation. Cell
1995, 81:495–504.
105. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach
D: A novel protein that interacts with the death domain of
Fas/APO1 contains a sequence motif related to the death
domain. J Biol Chem 1995, 270:7795–7798.
106. Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM: FADD, a novel
death domain-containing protein, interacts with the death domain
of Fas and initiates apoptosis. Cell 1995, 81:505–512.
107. Hsu H, Shu H-B, Pan M-P, Goeddel DV: TRADD-TRAF2 and
TRADDFADD interactions define two distinct TNF receptor-1
signal transduction pathways. Cell 1996, 84:299–308.
108. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer
PH, et al.: Cytoxicity-dependent APO-1(Fas/CD95)-associated
proteins (CAP) form a death-inducing signalling complex (DISC)
with the receptor. EMBO J 1995, 14:5579–5588.
109. Chinnaiyan AM, Tepper CG, Seldin MF, O’Rourke K, Kischkel FC,
Hellbardt S, et al.: FADD/MORT1 is a common mediator of CD95
(Fas/APO-1) and tumor necrosis factor receptor-induced
apoptosis. J Biol Chem 1996, 271:4961–4965.
110. Sugimoto A, Hozak RR, Nakashima T, Nishimoto T, Rothman JH:
dad-1, an endogenous programmed cell death suppressor in
Caenorhabditis elegans and vertebrates. EMBO J 1995,
14:4434–4441.
111. Nakashima T, Sekiguchi T, Kuraoka A, Fukushima K, Shibata Y,
Komiyama S, et al.: Molecular cloning of a human cDNA encoding
a novel protein, DAD1. Mol Cell Biol 1993, 13:6367–6374.
112. Opipari AW, Hu H-M, Yabkowitz R, Dixit VM: The A20 zinc finger
protein protects cells from tumor necrosis factor cytotoxicity. J
Biol Chem 1992, 267:12424–12427.
113. Jaattela M, Mouritzen H, Elling F, Bastholm L: A20 zinc finger protein
inhibits TNF and IL-1 signaling. J Immunol 1996, 156:1166–1173.
562 Current Biology 1996, Vol 6 No 5
